1 Department of Pediatrics, Rainbow Babies and Childrens Hospital, Case Western Reserve University, Cleveland
Cefamandole nafate is a relatively new cephalosporin approved for use in pediatric patients. This compound offers certain advantages over previously approved cephalosporins including its in vitro antimicrobial activity against
-lactamase-producing Haemophilus influenzae. The purpose of this report is to describe a potential hazard associated with the use of this and closely related antimicrobial agents in life-threatening bacterial infections.
CASE REPORT
This was the first Rainbow Babies and Childrens Hospital admission for this 7-month-old boy with a ten-day history of fever and irritability. Seven days prior to admission he was seen by a local physician for fever. No source of infection was noted and the infant was treated with 300,000 units of intramuscular procaine penicillin.
This article has been cited by other articles:
![]() |
M. T. Brady, W. J. Barson, H. J. Cannon JR, and L. K. Grossman Onset of Hemophilus influenzae Type-b Meningitis During Cefaclor Therapy for Preseptal Cellulitis Clinical Pediatrics, March 1, 1987; 26(3): 132 - 134. [Abstract] [PDF] |
||||